Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular disease

Journal:
Annals of the Rheumatic Diseases
Published:
DOI:
10.1016/j.ard.2025.08.028
Affiliations:
19
Authors:
16
Institutions Authors Share
Pfizer, United States of America (USA)
3.000000
0.19
Pfizer R&D Groton, CT, United States of America (USA)
1.000000
0.06
UCLA Health, United States of America (USA)
1.000000
0.06
Pfizer - Philippines, Philippines
1.000000
0.06
Pfizer Norge, Norway
1.000000
0.06
NIHR Manchester Biomedical Research Centre (Manchester BRC), United Kingdom (UK)
1.000000
0.06
Pfizer, S.L., Spain
1.000000
0.06
Mayo Clinic, United States of America (USA)
1.000000
0.06
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
1.000000
0.06
University of Debrecen, Hungary
1.000000
0.06
Mount Sinai Heart, United States of America (USA)
1.000000
0.06
Cedars-Sinai Medical Center (Cedars-Sinai), United States of America (USA)
1.000000
0.06
University of Nebraska Medical Center (UNMC), United States of America (USA)
0.500000
0.03
VA Nebraska-Western Iowa Health Care System, United States of America (USA)
0.500000
0.03
Paris Cité University, France
0.250000
0.02
Cochin Hospital, France
0.250000
0.02
Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), France
0.250000
0.02
Biostatistics and clinical epidemiology, France
0.250000
0.02